News

View All Press Releases NCS in the News

Wingerter joins Nebraska Cancer Specialists

Tuesday, June 26, 2018
Follow the link below to read more about our new Licensed Independent Mental Health Professional, Lori... Read more

Elkhorn man with rare cancer still teaches exercise classes

Tuesday, May 8, 2018
'I'm going to fight it like hell': Elkhorn man with rare cancer still teaches exercise classes Jeff Strufing isn't letting cancer slow him down.... Read more

What You Need to Know Now About Testicular Cancer

Wednesday, April 25, 2018
What You Need to Know Now About Testicular Cancerby Dr. Ralph Hauke Click on the pdf above to read an article written by Dr. Hauke for Methodist... Read more

Dr. Hauke talks about Melanoma on The Morning Blend

Wednesday, April 18, 2018
Dr. Ralph Hauke was on The Morning Blend to discuss Melanoma and what to do to prevent... Read more

Dr. Bernie Su - Meaning of Care Award

Wednesday, February 14, 2018
Dr. Bernie Su received the Meaning on Care Award. This award is sponsored by the Methodist Hospital Foundation, which is a program created for... Read more

Ribbon Cutting at Hope Lodge

Wednesday, January 31, 2018
The Hope Lodge Nebraska offers rest and serenity for cancer patients traveling from far away to seek treatment in the metro.  Click here for the full... Read more

Dr. Block discusses Breast Cancer and current trials on The Morning Blend

Wednesday, October 4, 2017
Dr. Block was on The Morning Blend to discuss Breast Cancer and the current trials. Click on the link below to... Read more

Dr. Ralph Hauke Named Advocacy Champion by the American Society of Clinical Oncology

Wednesday, October 4, 2017
Nebraska Cancer Specialists, Dr Ralph Hauke Named Advocacy Champion by the American Society of Clinical Oncology ALEXANDRIA, Va – The American Society of Clinical... Read more

Dr. Hauke discusses Immunotherapy on The Morning Blend

Monday, August 14, 2017
Dr Hauke was on The Morning Blend to discuss Immunotherapy. Click on the link below for more... Read more

Clinical Trial Evaluating Investigational Medication for HER2-Positive Breast Cancer

Wednesday, August 9, 2017
We are conducting a clinical trial of an investigational medication for HER2-positive breast cancer. The randomized pivotal study, called HER2CLIMB,... Read more